These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25847979)

  • 41. Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.
    Takahashi K; Serruys PW; Gao C; Ono M; Wang R; Thuijs DJFM; Mack MJ; Curzen N; Mohr FW; Davierwala P; Milojevic M; Wykrzykowska JJ; de Winter RJ; Sharif F; Onuma Y; Head SJ; Kappetein AP; Morice MC; Holmes DR;
    Circulation; 2021 Jul; 144(2):96-109. PubMed ID: 34011163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
    Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    Stone GW; Sabik JF; Serruys PW; Simonton CA; Généreux P; Puskas J; Kandzari DE; Morice MC; Lembo N; Brown WM; Taggart DP; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman P; Bochenek A; Schampaert E; Pagé P; Dressler O; Kosmidou I; Mehran R; Pocock SJ; Kappetein AP;
    N Engl J Med; 2016 Dec; 375(23):2223-2235. PubMed ID: 27797291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study.
    Wang R; Tomaniak M; Takahashi K; Gao C; Kawashima H; Hara H; Ono M; van Klaveren D; van Geuns RJ; Morice MC; Davierwala PM; Mack MJ; Witkowski A; Curzen N; Berti S; Burzotta F; James S; Kappetein AP; Head SJ; Thuijs DJFM; Mohr FW; Holmes DR; Tao L; Onuma Y; Serruys PW
    Clin Res Cardiol; 2021 Jul; 110(7):1083-1095. PubMed ID: 33710385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
    Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
    J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
    Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
    J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease.
    Kodumuri V; Balasubramanian S; Vij A; Siddamsetti S; Sethi A; Khalafallah R; Khosla S
    Am J Cardiol; 2018 Apr; 121(8):924-933. PubMed ID: 29502793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Park DW; Ahn JM; Park H; Yun SC; Kang DY; Lee PH; Kim YH; Lim DS; Rha SW; Park GM; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ;
    Circulation; 2020 May; 141(18):1437-1446. PubMed ID: 32223567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
    Thuijs DJFM; Kappetein AP; Serruys PW; Mohr FW; Morice MC; Mack MJ; Holmes DR; Curzen N; Davierwala P; Noack T; Milojevic M; Dawkins KD; da Costa BR; Jüni P; Head SJ;
    Lancet; 2019 Oct; 394(10206):1325-1334. PubMed ID: 31488373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.
    Kawashima H; Serruys PW; Hara H; Ono M; Gao C; Wang R; Garg S; Sharif F; de Winter RJ; Mack MJ; Holmes DR; Morice MC; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Onuma Y;
    JACC Cardiovasc Interv; 2022 Jan; 15(2):193-204. PubMed ID: 34973904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Myocardial Infarction and Left Main or Multivessel Coronary Disease.
    Freitas P; Madeira M; Raposo L; Madeira S; Brito J; Brízido C; Gama F; Vale N; Ranchordás S; Magro P; Braga A; Gonçalves PA; Gabriel HM; Nolasco T; Boshoff S; Marques M; Bruges L; Calquinha J; Sousa-Uva M; Abecasis M; Almeida M; Neves JP; Mendes M
    Am J Cardiol; 2019 Mar; 123(5):717-724. PubMed ID: 30558758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
    Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L;
    Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
    Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial.
    Chen S; Redfors B; Liu Y; Vrolix M; Macaya C; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Coron Artery Dis; 2019 Mar; 30(2):143-149. PubMed ID: 30531253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease.
    Patterson T; McConkey HZR; Ahmed-Jushuf F; Moschonas K; Nguyen H; Karamasis GV; Perera D; Clapp BR; Roxburgh J; Blauth C; Young CP; Redwood SR; Pavlidis AN
    J Am Heart Assoc; 2019 Apr; 8(8):e011279. PubMed ID: 30943827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Impact of Multiple Prior Percutaneous Coronary Interventions in Patients Undergoing Coronary Artery Bypass Grafting.
    Biancari F; Dalén M; Ruggieri VG; Demal T; Gatti G; Onorati F; Faggian G; Rubino AS; Maselli D; Gherli R; Salsano A; Saccocci M; Santarpino G; Nicolini F; Tauriainen T; De Feo M; Airaksinen J; Rosato S; Perrotti A; Mariscalco G
    J Am Heart Assoc; 2018 Oct; 7(20):e010089. PubMed ID: 30371287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.